Literature DB >> 23515052

Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction.

Walid Beghdadi1, Lydia C Madjene, Julien Claver, Gunnar Pejler, Lucie Beaudoin, Agnès Lehuen, Eric Daugas, Ulrich Blank.   

Abstract

Mast cell release of chymase is important in tissue remodeling and may participate in inflammation leading to fibrosis and organ failure. Here we analyzed the function of chymase in unilateral ureteral obstruction, an established accelerated model of renal tubulointerstitial fibrosis. Mice deficient in mouse mast cell protease 4 (mMCP4), the functional counterpart of human chymase, had increased obstruction-induced fibrosis when compared to wild-type mice indicating a protective effect of mMCP4. Engraftment of mast cell-deficient Kit(Wsh/Wsh) mice with wild type, but not mMCP4-deficient mast cells, restored protection confirming the role of mMCP4. Kidneys of mMCP4-deficient mice had higher levels of renal tubular damage, interstitial fibrosis, collagen deposition, increased α-smooth muscle actin, and decreased E-cadherin expression compared to the kidneys of wild-type mice. Further analysis showed an elevated inflammatory response in mMCP4-deficient mice with increased levels of kidney-infiltrating macrophages and T cells and local profibrotic TGF-β1 and CCL2. Granulated and degranulated mast cells and mMCP4 were mainly found in the kidney capsule, respectively, before and after ureteral obstruction. Analysis of mMCP4 substrates showed that it mediates its anti-fibrotic actions by degrading interstitial deposits of fibronectin, a known promoter of inflammatory cell infiltration and adhesion. Thus, mast cell released mMCP4 has anti-fibrotic potential in acutely induced obstructive nephropathy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23515052     DOI: 10.1038/ki.2013.98

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

Review 1.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

Review 2.  Mast cell secretory granules: armed for battle.

Authors:  Sara Wernersson; Gunnar Pejler
Journal:  Nat Rev Immunol       Date:  2014-06-06       Impact factor: 53.106

Review 3.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

Review 4.  Novel Insight into the in vivo Function of Mast Cell Chymase: Lessons from Knockouts and Inhibitors.

Authors:  Gunnar Pejler
Journal:  J Innate Immun       Date:  2020-06-04       Impact factor: 7.349

Review 5.  Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling.

Authors:  Louis J Dell'Italia; James F Collawn; Carlos M Ferrario
Journal:  Circ Res       Date:  2018-01-19       Impact factor: 17.367

6.  The role of macrophage migration inhibitory factor in mast cell-stimulated fibroblast proliferation and collagen production.

Authors:  Gu Ningyan; Yao Xu; Shi Hongfei; Chen Jingjing; Chen Min
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

7.  Mast Cells and MCPT4 Chymase Promote Renal Impairment after Partial Ureteral Obstruction.

Authors:  Maguelonne Pons; Liza Ali; Walid Beghdadi; Luca Danelli; Marianne Alison; Lydia Celia Madjène; Jessica Calvo; Julien Claver; Shamila Vibhushan; Magnus Åbrink; Gunnar Pejler; Marie-Laurence Poli-Mérol; Michel Peuchmaur; Alaa El Ghoneimi; Ulrich Blank
Journal:  Front Immunol       Date:  2017-05-04       Impact factor: 7.561

8.  Mast Cell Degranulation Exacerbates Skin Rejection by Enhancing Neutrophil Recruitment.

Authors:  Flavie Ngo Nyekel; Emeline Pacreau; Samira Benadda; Rasha Msallam; Magnus Åbrink; Gunnar Pejler; Jean Davoust; Marc Benhamou; Nicolas Charles; Pierre Launay; Ulrich Blank; Gregory Gautier
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

9.  IL-6 and IL-17A degradation by mast cells is mediated by a serglycin:serine protease axis.

Authors:  Ida Waern; Iulia Karlsson; Gunnar Pejler; Sara Wernersson
Journal:  Immun Inflamm Dis       Date:  2015-12-02

10.  Resveratrol improves prostate fibrosis during progression of urinary dysfunction in chronic prostatitis by mast cell suppression.

Authors:  Huizhi Zeng; Yi He; Yang Yu; Jiashu Zhang; Xiaona Zeng; Fengtao Gong; Qi Liu; Bo Yang
Journal:  Mol Med Rep       Date:  2017-11-03       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.